Providence Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.83M Buy
68,442
+1,832
+3% +$163K 0.95% 47
2025
Q4
$5.26M Sell
66,610
-603
-0.9% -$47.3K 0.89% 47
2025
Q3
$5.37M Buy
+67,213
New +$5.73M 0.93% 46
2022
Q1
Sell
-35
Closed -$3K 473
2021
Q4
$3K Hold
35
﹤0.01% 292
2021
Q3
$3K Hold
35
﹤0.01% 268
2021
Q2
$3K Sell
35
-37,700
-100% -$3.08M ﹤0.01% 274
2021
Q1
$2.98M Buy
37,735
+37,700
+107,714% +$2.95M 1.08% 44
2020
Q4
$3K Hold
35
﹤0.01% 273
2020
Q3
$3K Sell
35
-45,365
-100% -$3.46M ﹤0.01% 183
2020
Q2
$3.33M Buy
45,400
+2,050
+5% +$146K 1.89% 12
2020
Q1
$2.88M Buy
43,350
+43,100
+17,240% +$3.04M 1.73% 14
2019
Q4
$17K Hold
250
0.01% 157
2019
Q3
$18K Hold
250
0.01% 144
2019
Q2
$18K Hold
250
0.01% 146
2019
Q1
$17K Hold
250
0.01% 157
2018
Q4
$15K Hold
250
0.01% 169
2018
Q3
$17K Hold
250
0.01% 172
2018
Q2
$16K Hold
250
0.01% 163
2018
Q1
$18K Sell
250
-205
-45% -$14.8K 0.01% 153
2017
Q4
$34K Buy
+455
New +$33.2K 0.03% 133

Other funds holding CL

Providence Capital Advisors's CL Position: Q1 2026 in Review

Providence Capital Advisors increased its Colgate-Palmolive (CL) stake by 2.8% in Q1 2026, buying an estimated $163K and bringing the position to 68,442 shares worth $5.83M. The position accounts for 0.95% of the portfolio, ranked #47.

Providence Capital Advisors first reported a position in CL in Q4 2017 and has held it in 20 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Providence Capital Advisors held 68,442 shares of Colgate-Palmolive worth $5.83M as of Q1 2026.
  • Providence Capital Advisors bought 1,832 Colgate-Palmolive shares in Q1 2026, an estimated $163K.
  • Colgate-Palmolive made up 0.95% of Providence Capital Advisors's portfolio in Q1 2026, its #47 holding.
  • Providence Capital Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 20 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Providence Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.